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Vitamins belong to a group of organic com-
pounds which are essential in very small amounts
for the normal growth, self-maintenance and func-
tioning of human and animal bodies. They fulfill
different specific and vital functions in metabolism,
and their lack or excess produces specific diseases.
Vitamin A is a micronutrient, essential for bio-
logical processes such as vision, reproduction, cell
growth and differentiation and embryonic develop-
ment in most mammalian species. The term vitamin
A describes a group of lipid-soluble compounds
(retinyl esters) related metabolically to all-trans
retinol. Vitamin A in its various forms functions as
a hormone and it is also an essential component of
the visual cycle. Deficiency of vitamin A leads to a
variety of symptoms in humans, including dryness
of the skin, eyes and mucous membranes, retarded
development and growth and night blindness, an
early symptom commonly used in diagnosis of vita-
min A deficiency (1). 
Vitamin A combined with other substances of
natural origin, such as propolis extract and calendu-
la extract and with broad-spectrum antibiotic baci-
tracin, accelerates growth of skin cells, protects
from infections and purifies injuries from metabolic
products. 
In the literature, several methods have been
proposed for the determination of vitamin A that
include flow injection analysis (2), LC-MS (3), RP-
HPLC with UV detection (4, 5), RP-HPLC with
electrochemical detection (6), HPLC-isotope dilu-
tion mass spectrometry (7), and simple HPLC (8-
13). 
An extraction step prior to determination of
vitamins is normally required as sample pretreat-
ment. 
The aim of this paper was the development and
validation of new RP-HPLC method for the deter-
mination of vitamin A in the ointment containing in
100 g standardized calendula flower extract 9.0 g,
standardized propolis extract 3.0 g, bacitracin 1.0 g,
retinyl palmitate 0.03 g, anhydrous lanolin, flaxseed
oil, white vaseline, solid paraffin and cholesterol.
EXPERIMENTAL
Chemicals and reagents
Retinyl palmitate 1,7 mIU/g ñ DSM
Nutritional Products Ltd., lot no. UT05040160.
Methanol, water and n-hexane of HPLC purity; all
manufactured by Merck.
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Abstract: A simple and rapid HPLC with diode array detection method was developed for the determination
of retinyl palmitate present together with other active substances in an ointment. Chromatographic separation
was performed on 100 RP-18 Lichrospher column of particle size 5 µm. The mobile phase was methanol:water
(98:2, v/v) and flow rate was 2.0 mL/min in isocratic mode. Samples were analyzed for 30 min.
Spectophotometric detection was conducted at 325 nm. Under these conditions, the method featured high sen-
sitivity, good precision and comparability of results as proven by the method validation and statistical analysis
of the results. The limits of detection and determination were 0.4317 mg/100 mL and 1.3081 mg/100 mL,
respectively, recovery values were measured at three levels 80%, 100% and 120% and yielded 101.05%,
101.34% and 100.43%, respectively. The linearity range was checked from 2 mg/100 mL to 10 mg/100 mL.
The precision and inter-day precision of the method was expressed by relative standard deviation value and did
not exceed 1.68%. 
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Instrumentation and chromatography
The HPLC system consisted of pump L-2130,
autosampler L-2200, diode array detector L-2455
and thermostat L-2350 all manufactured by Merck-
Hitachi. 
Separation was achieved using LiChrosphere
100 RP-18 column (4.6 ◊ 250 mm; 5 µm particles,
Merck). The isocratic mobile phase pumped at a
flow rate of 2 mL/min consisted of methanol and
water (98:2 v/v) freshly prepared. Autosampler was
used for the injection of samples. The injection vol-
ume was 20 µL and the wavelength for detection
was 325 nm. All separations were performed at
40OC for 30 min. 
Standard solutions
Stock standard solution of retinyl palmitate
was prepared by dissolving 100 mg of drug in 100
mL of n-hexane. Standard solutions for linearity (2,
4, 6, 8, 10 mg/100 mL) were prepared by subsequent
dilution using n-hexane. 
Placebo solution
Placebo in the amount of 2 g was shaken with
20 mL of n-hexane for 30 min and filtered.
Specificity solution
Retinyl palmitate in the amount of 6 mg was
dissolved in 100 ml of n-hexane.
Standard solution for quantification
Standard solution was prepared in n-hexane by
dilution of stock solution of retinyl palmitate to
obtain a concentration of 3 mg/100 mL.
Preparation
Ointment containing standardized calendula
flower extract 9.0 g, standardized propolis extract
3.0 g, bacitracin 1.0 g, retinyl palmitate 0.03 g,
anhydrous lanolin, flaxseed oil, white vaseline, solid
paraffin, and cholesterol in 100.0 g was prepared in
Table 1. Results from system suitability analysis.
Injection Retinyl palmitate
No. Peak area Retention time Theoretical plates Peak symmetry
1 8258229 19.353 4810 0.909
2 8238033 19.507 4447 0.924
3 8171655 19.487 4510 0.909
4 8215072 19.547 4473 0.893
5 8159164 19.140 4607 0.908
Mean 8208430.6 19.407 4569.4 0.909
RSD 0.52% 0.86% 3.23% 1.21%  
Figure 1. Absorption spectrum of retinyl palmitate
Figure 2. Chromatogram of retinyl palmitate standard solution
Figure 3. Chromatogram registered for placebo solution
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Table 2a. Results from method validation. 
Parameter Retinyl palmitate  
RT (n = 5) 19.40 min
RSD = 0.86%
P = -303 ◊103 + 1440 ◊103 c
Linearity r = 0.9994
Se = 1883 ◊ 102
Linearity range 
[mg/100 mL] 2 ñ 10
LOD [mg/100 mL] 0.4317
LOQ [mg/100 mL] 1.3081
from 3860361 to 4021299
mean 3941439.2
RSD = 1.46%
Precision [area] from 8084304 to 8285621
RSD  mean 8187418
RSD = 1.12%
from 12712714 to 13158456
mean 13041472
RSD = 1.40%
from 3847483 to 3944292
mean 3903552.2
Inter-day precision RSD = 1.17%
[area] from 8040959 to 8355905
RSD mean 8183126.2 
RSD = 1.35%
from 13064434 to 13638367
mean 13466021.2
RSD = 1.68%
Mean recovery n = 3
80% level 101.05%
100% level 101.34%
120% level 100.43 %
accordance with the Polish Pharmacopoeia (FP VII).
The constituents were weighed with an accuracy of
0.1 mg. 
Preparation of solution
The solution was prepared by weighing 1 g of
ointment with the accuracy of 0.1 mg and shaking
with 10 mL of n-hexane in 25 mL flask in an ultra-
sonic bath for 10 min. The solution was filtered
through hard filter paper. 
Method validation
The method was validated according to the
guidelines set on the International Conference on
Harmonisation (ICH) for the validation of analytical
procedures (14). The parameters which were used to
validate the method of analysis were: system suit-
ability, linearity, limit of detection (LOD), limit of
quantitation (LOQ), precision, intermediate preci-
sion, accuracy, specificity, robustness and stability
of solutions. 
System suitability
The system suitability parameters: area
repeatability, symmetry factor and number of theo-
retical plates were calculated.
Linearity
Linearity was determined as the relationship of
peak areas to concentration. The chromatograms of
retinyl palmitate standard solutions were recorded
and the changes of peak areas were analyzed within
the concentrations of 2 ñ 10 mg/100 mL. The results
were analyzed using the linear regression method.
The regression plot, regression equation and the cor-
relation coefficient are indicative of linearity.
Limits of detection and quantitation
Using standard deviation and slope of a
straight line coefficient, the values of LOD and LOQ
were determined using the following equations:
LOD = 3.3◊Se/a, LOQ = 10◊Se/a, where: Se = stan-
dard error of the estimate, a = slope of a straight line. 
Precision and inter-day precision
The precision was checked at three levels. Three
stock solutions were prepared by weighing 0.3, 0.6 and
0.9 g of retinyl palmitate and dissolving in 100 mL of
n-hexane. 1 mL of each solution was diluted to 100 mL
Table 2b. Results from method validation. Robustness. 
Parameter
Oven temperature 
RT [min] Peak area Theoretical plates Peak symmetry[OC] 
36OC 21.467 8145877 3971 0.965
40OC 19.407 8208430 4569 0.909 
44OC 17.873 8091129 4607 0.946
Flow rate
[mL/min.] 
RT min Peak area Theoretical plates Peak symmetry
1.8 21.807 8980563 4527 0.964
2.0 19.407 8208430 4569 0.909
2.2 18.113 7032939 4523 0.959
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with n-hexane and five measurements were carried out
for each solution. The precision was expressed as the
consistency of results from repeated analyses. Peak
areas were used to evaluate method precision. 
The same methodology was applied for check-
ing inter-day precision, but chromatograms were
registered the next day. 
Accuracy
Accuracy was determined by quantitative
determination of retinyl palmitate added to model
mixture at three levels 80%, 100% and 120%.
Recovery was calculated on the basis of determined
content of retinyl palmitate to weighed amount
added to model mixture.
Specificity
Specificity of the method was evaluated by
comparing chromatograms registered for mobile
phase, placebo solution and retinyl palmitate stan-
dard solution. 
Robustness
Effect of flow rate variations (± 0.2 mL/min)
and temperature of column oven (± 4OC) on the
obtained results was checked. 
Stability of solutions
Stability of stock solution was determined by
the analysis of solutions that were stored at room
temperature and in refrigerator at 8OC. Analysis was
carried out for freshly prepared solution and after
storage for 1, 2, and 7 days. 
Quantitative analysis
Volumes of 20 µL standard and sample solu-
tions were introduced onto the column five times.
Isocratic elution was carried out under conditions
specified by using mobile phase of the composition
described above. Peak areas were registered and
used for the calculation of retinyl palmitate content. 
RESULTS AND DISCUSSION
The development of new, simple and precise
methods for the determination of active substances
is still an important problem due to creating new
pharmaceutical formulations with complex matrix.
Table 3. Stability studies of retinyl palmitate stock solution.
Time 
Temperature 8OC Room temperature   
Peak area [%] Peak area [%]
9228980 9820004
0 9241322 100,00 9920637 100,00
9089099 10033711
mean 9186467  mean 9924784
9100467 9891139
24 h 9147231 99,79 9843768 98,98
9252711 9736271
mean 9166803  mean 9823726
9092498 9866924
48 h 9140627 99,36 9757005 99,03 
9149305 9861983
mean 9127477  mean 9828637
9124002 9645414
7 days 9141039 99,69 9802678 98,33
9209299 9829530
mean 9158113 mean 9759207
Table 4. Results of quantitative HPLC analyses of retinyl palmitate in the ointment.
Retinyl palmitate concentration
mg/100 mL
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The chromatographic conditions were opti-
mized and determination was performed on a 100
RP-18 Lichrospher column using a mobile phase
consisting of methanol and water 98:2, v/v with
flow rate of 2.0 mL/min in isocratic mode. 
Analytical wavelength λ = 325 nm was chosen
based on the absorption spectrum registered in UV
with the application of DAD detector (Fig. 1).
The results of system suitability test for the deter-
mination of retinyl palmitate are presented in Table 1. 
The obtained results met the acceptance criteria.
Repeatability of peak area for five replicates described
by RSD was 0.52%, repeatability of retention time for
five replicates was described by RSD = 0.86%, the
mean value of theoretical plates was 4569.4 (RSD =
3.23% for n = 5) and the mean value of peak symme-
try was 0.909 (RSD = 1.21% for n = 5).
The applied mobile phase composition allowed
suitable retention time of retinyl palmitate and good
selectivity towards interference from the excipients and
other components of the ointment was achieved (Fig. 2,
3). Standardized calendula flower extract, standardized
propolis extract, bacitracin, anhydrous lanolin, flaxseed
oil, white vaseline, solid paraffin and cholesterol did not
give any peaks at the retention time of retinyl palmitate
(19.4 min. under developed conditions).
The specificity of the proposed method demon-
strates that the excipients present in an ointment do
not interfere with the drug peak. Thus the proposed
method may be useful for the quantitative determi-
nation of retinyl palmitate in the examined ointment.
Calibration curves were constructed using
three series of standard retinyl palmitate solutions in
the range 2 ñ 10 mg/100 mL. The equation of linear
regression P = -303 ◊103 + 1440 ◊103 c and statisti-
cal data Se = 1883 ◊ 102 describe the relationship
between peak area and concentration. The linearity
of calibration curve was described by high value of
correlation coefficient r = 0.9994.
Low values of LOD 0.4317 mg/100 mL and
LOQ 1.3081 mg/100 mL indicate that the method is
sensitive.
The precision and inter-day precision were
checked at three levels. Statistical evaluation
revealed that the method is highly precise, RSD was
in the range 1.12% ñ 1.68%.
Recovery results, measured at three levels
80%, 100% and 120% were 101.05%, 101.34% nad
100.43%, respectively, which prove the suitability
and accuracy of the proposed method. 
Little changes of flow rate and column oven
temperature did not cause any significant changes
when analyzing peak areas, retention time, theoreti-
cal plates or peak symmetry (Tab. 2a, b). 
Stability studies for stock solution revealed
that no significant changes (0.31% after 7 days of
storage at 8∞C and 1.67% after storage at room tem-
perature) were observed for stock solution concen-
tration (Tab. 3). 
The developed and validated method has been
applied for the quantitative determination of retinyl
palmitate in the examined ointment. The obtained
results are close to the declared content of retinyl
palmitate in the ointment from 2.794 mg/100 mL to
2.838 mg/100 mL with RSD values 0.299% and
0.340%, respectively, for n = 3 (Tab. 4). 
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